Tricyclic antitumor compounds being farnesyl protein transferase inhibitors

Details for Australian Patent Application No. 2007202115 (hide)

Owner Schering Corporation Pharmacopeia Drug Discovery, Inc.

Inventors Doll, Ronald J.; Wang, James; Baldwin, John J.; James, Ray A.; Desai, Jagdish A.; Huang, Chia-Yu; Alvarez, Carmen S.; Cooper, Alan B.; Vibulbhan, Bancha; Guzi, Timothy; Girijavallabhan, Viyyoor Moopil; Keertikar, Kartik M.; Rane, Dinanath F.; Bishop, Robert W.; Santhanam, Bama; Pinto, Patrick A.; Njoroge, F. George; Li, Ge; Minor, Keith P.; Zhu, Hugh Y.

Agent Griffith Hack

Pub. Number AU-A-2007202115

Parent 2001288451

Filing date 11 May 2007

Wipo publication date 31 May 2007

International Classifications

C07D 233/61 (2006.01) Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings

A61K 31/4545 (2006.01)

A61K 31/496 (2006.01) - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

A61K 31/5377 (2006.01)

A61K 31/5513 (2006.01)

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 35/00 (2006.01) Antineoplastic agents

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07D 221/16 (2006.01) Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups

C07D 401/04 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 401/06 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 401/10 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 405/06 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 409/06 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 409/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 413/06 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 413/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 521/00 (2006.01) Heterocyclic compounds containing unspecified hetero rings

Event Publications

31 May 2007 Application Open to Public Inspection

  Published as AU-A-2007202115

31 May 2007 Complete Application Filed

13 September 2007 Assignment before Grant

  Schering Corporation; Pharmacopeia Drug Discovery, Inc. The application has been assigned to Schering Corporation; Pharmacopeia, Inc.

25 March 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007202116-Wheel hub shipping retainer system

2007202114-Sand barrier for a level 3 multilateral wellbore junction